MCL1 and acute myeloid leukemia: AML cell lines MOLM-13 and OCI-AML3, which were susceptible to S63845, had elevated MCL1 levels, while OCI-AML2 and MOLM-16, which were resistant to S63845, had reduced MCL1 levels.